“Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design”, Dhaka Univ. J. Pharm. Sci, vol. 23, no. 2, pp. 135–143, Dec. 2024, doi: 10.3329/dujps.v23i2.78571.